Post by
beechguy on Nov 05, 2013 12:02pm
ENDO Paladin Bioniche conspiracy...
Since everyone is talking conspiracy theories. What if Endo flopped our trial on purpose to pick at the table scraps afterwards? They turned down all applicants (except a few) and make it look impossible to enroll patients. How could they possibly have had a hard time filling the 3B trial, when your options are MMC (chemotherapy), Urocidin or Bladder removal and its quality of life issues??? I know I would choose a new trial, yet they couldn’t find enough willing participants??? There are 50k BC refractory patients annually in the US alone. They only found what 20... or 30??
Maybe Bioniche was suing Endo for breach of contract, and Endo instead chose to walk away with 5% and Bioniche agreed to an iron clad non disclosure agreement. (like that is needed with these guys)
Endo would know that a platform to serve a massive BC refractory market would be immense in market scope. Likely 2 to 5 times the revenue Paladin currently has, and they would know it works. Now they buy Paladin, (Endo does of course want their 200mm revenue), but really wants the 500mm to 1B an FDA/ EU approved Urocidin could offer up. This makes an acquisition that much easier and now have insiders lurking all over the company and the BOD.
Don’t forget companies buy phase 2 long shots all the time for big $$. Bioniche has a complete phase 3 and almost zero safety issues.
Just a theory, but where there's smoke....
Either way we are unlikely to benefit from this as the little guy always gets screwed (especially with this outfit)
Is anyone going to the AGM? I’ll be the guy out front with the tin cup and the carboard sign that says "will work for BNC dividend". Seriously though, I will be in the parking lot at 3:45 if anyone wants to meet up.
beech
Comment by
conspiTheory on Nov 05, 2013 12:12pm
as per Endo itself, UROCIDIN is a 100 millions, One hundred million estimated peak year sale drug no more. it is written on their 2012 investor day meeting page 75.
Comment by
beechguy on Nov 05, 2013 12:43pm
The Jefferies Endo analyst said $345,000,000 in US sales alone.
Comment by
DryBones on Nov 05, 2013 12:47pm
This post has been removed in accordance with Community Policy
Comment by
conspiTheory on Nov 05, 2013 1:44pm
so BNC can dilute to a billion shares to match the price, great...
Comment by
Verta on Nov 05, 2013 1:54pm
Let's not forget that Uorcidin is the type of the iceberg - if it is successful where else can MCC go?